The role for cardiopulmonary exercise testing in patients with atrial septal defects: a review

Anthony J Barron1, Roland Wensel, Darrel P Francis

  • 1International Centre for Circulatory Health, Imperial College London and Imperial College NHS Trust, UK. anthonybarron@hotmail.co.uk

Insights

Secundum atrial septal defects (ASD) are common congenital heart issues. Cardiopulmonary exercise testing (CPET) may help identify patients who benefit from ASD closure, improving outcomes.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Diagnostic Tools

Background:

  • Secundum atrial septal defects (ASD) are common congenital heart abnormalities.
  • Untreated ASD can lead to significant morbidity and mortality, including heart failure and pulmonary hypertension.
  • Historically, surgical closure was limited to large defects due to procedure-related morbidity.

Purpose of the Study:

  • To review the current evidence for using cardiopulmonary exercise testing (CPET) in guiding atrial septal defect (ASD) closure decisions.
  • To explore objective measures of exercise capacity as an alternative to subjective symptoms or signs of shunt/heart failure.
  • To evaluate the role of CPET in identifying patients who would benefit from ASD closure.

Main Methods:

  • Review of existing literature on atrial septal defect closure and cardiopulmonary exercise testing.
  • Analysis of studies comparing outcomes of surgical versus percutaneous ASD closure.
  • Examination of the utility of CPET in assessing exercise capacity in patients with ASD.

Main Results:

  • Percutaneous ASD closure has become first-line, increasing utilization despite significant morbidity.
  • Traditional criteria for ASD closure (symptoms, shunt size, RV failure) may not identify all patients who could benefit.
  • CPET offers an objective measure of exercise capacity that may aid in selecting appropriate candidates for ASD closure.

Conclusions:

  • The increased utilization of ASD closure, particularly percutaneous methods, necessitates refined patient selection criteria.
  • Cardiopulmonary exercise testing (CPET) shows promise as an objective tool to identify patients with ASD who may benefit from closure.
  • Further research is warranted to establish definitive guidelines for CPET in ASD management.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...